Is INVO Fertility, Inc. (IVF) overvalued? · rev $6.8M
INVO Fertility, Inc. (IVF) is a medical devices company listed on US.
This page asks whether INVO Fertility, Inc. (IVF) looks expensive on cached numbers — not a short thesis.
Latest reported IVF revenue for 2025-12-31 was $6.8M. Net income was -$23.3M. Revenue was up 4.7% from 2024-12-31 to 2025-12-31. IVF currently screens at market cap $2.8M.
IVF currently screens at market cap $2.8M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next IVF 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the IVF stock page for the full model, not this heading.
Not investment advice.